MedPath
TGA Approval

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial (400874)

400874

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial

Pfizer Australia Pty Ltd

January 23, 2023

Medicine

Medicine

Active

Registered - Prescription

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/87f72f1b7cf52abd018ed0370240b90b.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/67cddfe33876751fcdc6f8a06aea1ba4.pdf

Active Ingredients

famtozinameran

tozinameran

© Copyright 2025. All Rights Reserved by MedPath
COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial (400874) - TGA 批准文号 | MedPath